透视引导下经皮经肝取石术治疗胆管结石的多中心回顾性队列研究结局
该多中心回顾性队列研究纳入2001年5月至2019年12月六家机构2431例接受透视引导下经皮经肝取石的胆管结石患者,技术成功率99.1%,早期并发症发生率8.1%,30天死亡率1.9%;1673例获得长期随访(中位41.5个月),结石复发率24.8%,中位复发间隔27.9个月,年龄、性别、结石位置、结石大小和胆囊状态为复发危险因素。
要点
- 经皮经肝取石技术成功率99.1%(2409/2431),早期并发症8.1%,30天死亡率1.9%。
- 长期随访中结石复发率24.8%(415/1673),中位复发间隔27.9个月,多次复发占4.4%。
- 年龄、性别、结石位置、结石大小和胆囊状态是结石复发的危险因素。
核心结论
- 经皮经肝取石是有效方法,初始成功率高、并发症率可接受,主要长期并发症为胆管结石复发。
研究设计与样本
- 多中心回顾性队列研究,纳入六家机构2001年5月至2019年12月连续2431例胆管结石患者(中位年龄75岁,IQR 66-81岁;男性1336例),采用Wittich镍钛取石篮配合12-F鞘在透视引导下取石。
诊断标准与关键数值
- 技术成功2409/2431(99.1%);早期并发症197/2431(8.1%),其中轻微并发症117/2431(4.8%)、严重并发症80/2431(3.3%);30天死亡率47/2431(1.9%);1673例(68.8%)获长期随访,中位随访41.5个月,结石复发415例(24.8%),中位复发间隔27.9个月,多次复发74例(4.4%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Although long-term follow-up data after endoscopic treatment of bile duct stones have been extensively evaluated, most studies investigating percutaneous treatment have had relatively small patient samples and short follow-up periods. Purpose To evaluate immediate and long-term outcomes in patients who underwent percutaneous transhepatic removal of bile duct stones in a multicenter retrospective cohort study. Materials and Methods Patients with bile duct stones who underwent percutaneous transhepatic stone removal at six institutions between May 2001 and December 2019 were included. A Wittich nitinol stone basket with a 12-F sheath was used to extract the stones with fluoroscopic guidance. Immediate technical success rate, incidence of early complications (≤30 days), and long-term outcomes were evaluated. Mixed-effects logistic regression models were used to identify factors predictive of stone recurrence. Results Data from 2431 consecutive patients (median age, 75 years [IQR, 66-81 years]; 1336 male patients) with bile duct stones (1985 patients with extrahepatic duct stones, 217 with intrahepatic duct stones, 229 with both) were evaluated. Technical success was achieved in 2409 of 2431 patients (99.1%). The overall incidence of early complications was 8.1% (197 of 2431 patients; minor complications, 117 of 2431 [4.8%]; major complications, 80 of 2431 [3.3%]). The 30-day mortality rate was 1.9% (47 of 2431). Long-term information was obtained for 1673 patients (68.8%), with a median follow-up period of 41.5 months. During follow-up, bile duct stone recurrence was observed in 415 patients (24.8%), with a median interval of 27.9 months; multiple recurrences occurred in 74 patients (4.4%). Bile duct carcinoma, pancreatic carcinoma, and liver cirrhosis developed in three, one, and two patients, respectively. Age, sex, stone location, stone size, and gallbladder status were identified as risk factors for stone recurrence. Conclusion Percutaneous transhepatic removal of bile duct stones was an effective procedure, with a high initial success rate and acceptable complication rates. The major long-term complication was bile duct stone recurrence. © RSNA, 2025 Supplemental material is available for this article.
引用
- Jung GS, Kim YJ, Yun JH, et al. Outcomes of Fluoroscopy-guided Percutaneous Transhepatic Removal of Bile Duct Stones: A Multicenter Retrospective Cohort Study. Radiology. 2025. PMID: 41186472. doi:10.1148/radiol.243951
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。